Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1997 Sep;65(9):3939–3943. doi: 10.1128/iai.65.9.3939-3943.1997

Use of cellular depletion analysis to examine circulation of immune effector function between the vagina and the periphery.

P L Fidel Jr 1, W Luo 1, J Chabain 1, N A Wolf 1, E Van Buren 1
PMCID: PMC175562  PMID: 9284175

Abstract

Results from an animal model of vaginal candidiasis suggest that Candida-specific cell-mediated immunity in the systemic circulation does not mediate protection against vaginitis. The present study used cellular depletion analysis to examine the circulation of immune effector function between the vagina and the periphery. Results showed that anti-Thy-1.2 antibodies given intravenously to mice depleted Thy-1+ T lymphocytes in the systemic compartment but not in the vaginal mucosa, while the same antibodies injected intravaginally significantly reduced Thy-1+ T cells in both the vaginal and systemic compartments. These results support a lack or low level of circulation of immune effector function from the periphery to the vaginal mucosa.

Full Text

The Full Text of this article is available as a PDF (256.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fidel P. L., Jr, Lynch M. E., Conaway D. H., Tait L., Sobel J. D. Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect Immun. 1995 Feb;63(2):547–553. doi: 10.1128/iai.63.2.547-553.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fidel P. L., Jr, Lynch M. E., Redondo-Lopez V., Sobel J. D., Robinson R. Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis. 1993 Dec;168(6):1458–1465. doi: 10.1093/infdis/168.6.1458. [DOI] [PubMed] [Google Scholar]
  3. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Candida-specific Th1-type responsiveness in mice with experimental vaginal candidiasis. Infect Immun. 1993 Oct;61(10):4202–4207. doi: 10.1128/iai.61.10.4202-4207.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Candida-specific cell-mediated immunity is demonstrable in mice with experimental vaginal candidiasis. Infect Immun. 1993 May;61(5):1990–1995. doi: 10.1128/iai.61.5.1990-1995.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis. Infect Immun. 1995 Jul;63(7):2403–2408. doi: 10.1128/iai.63.7.2403-2408.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fidel P. L., Jr, Lynch M. E., Sobel J. D. Effects of preinduced Candida-specific systemic cell-mediated immunity on experimental vaginal candidiasis. Infect Immun. 1994 Mar;62(3):1032–1038. doi: 10.1128/iai.62.3.1032-1038.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fidel P. L., Jr, Wolf N. A., KuKuruga M. A. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun. 1996 Sep;64(9):3793–3799. doi: 10.1128/iai.64.9.3793-3799.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fischer A., Ballet J. J., Griscelli C. Specific inhibition of in vitro Candida-induced lymphocyte proliferation by polysaccharidic antigens present in the serum of patients with chronic mucocutaneous candidiasis. J Clin Invest. 1978 Nov;62(5):1005–1013. doi: 10.1172/JCI109204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fong I. W., McCleary P., Read S. Cellular immunity of patients with recurrent or refractory vulvovaginal moniliasis. Am J Obstet Gynecol. 1992 Mar;166(3):887–890. doi: 10.1016/0002-9378(92)91356-f. [DOI] [PubMed] [Google Scholar]
  10. Hocini H., Barra A., Bélec L., Iscaki S., Preud'homme J. L., Pillot J., Bouvet J. P. Systemic and secretory humoral immunity in the normal human vaginal tract. Scand J Immunol. 1995 Aug;42(2):269–274. doi: 10.1111/j.1365-3083.1995.tb03653.x. [DOI] [PubMed] [Google Scholar]
  11. Ibraghimov A. R., Sacco R. E., Sandor M., Iakoubov L. Z., Lynch R. G. Resident CD4+ alpha beta T cells of the murine female genital tract: a phenotypically distinct T cell lineage that rapidly proliferates in response to systemic T cell activation stimuli. Int Immunol. 1995 Nov;7(11):1763–1769. doi: 10.1093/intimm/7.11.1763. [DOI] [PubMed] [Google Scholar]
  12. Maloy K. J., Donachie A. M., Mowat A. M. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS. Eur J Immunol. 1995 Oct;25(10):2835–2841. doi: 10.1002/eji.1830251019. [DOI] [PubMed] [Google Scholar]
  13. Mowat A. M., Maloy K. J., Donachie A. M. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens. Immunology. 1993 Dec;80(4):527–534. [PMC free article] [PubMed] [Google Scholar]
  14. Parr M. B., Parr E. L. Langerhans cells and T lymphocyte subsets in the murine vagina and cervix. Biol Reprod. 1991 Mar;44(3):491–498. doi: 10.1095/biolreprod44.3.491. [DOI] [PubMed] [Google Scholar]
  15. Paterson P. Y., Semo R., Blumenschein G., Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol. 1971 Nov;9(5):595–602. [PMC free article] [PubMed] [Google Scholar]
  16. Romani L., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Puccetti P., Bistoni F. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol. 1993 Feb 1;150(3):925–931. [PubMed] [Google Scholar]
  17. Romani L., Mocci S., Bietta C., Lanfaloni L., Puccetti P., Bistoni F. Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun. 1991 Dec;59(12):4647–4654. doi: 10.1128/iai.59.12.4647-4654.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Thapar M. A., Parr E. L., Bozzola J. J., Parr M. B. Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM). Vaccine. 1991 Feb;9(2):129–133. doi: 10.1016/0264-410x(91)90269-c. [DOI] [PubMed] [Google Scholar]
  19. Thapar M. A., Parr E. L., Parr M. B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology. 1990 May;70(1):121–125. [PMC free article] [PubMed] [Google Scholar]
  20. Wu H. Y., Russell M. W. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect Immun. 1993 Jan;61(1):314–322. doi: 10.1128/iai.61.1.314-322.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Xu-Amano J., Jackson R. J., Fujihashi K., Kiyono H., Staats H. F., McGhee J. R. Helper Th1 and Th2 cell responses following mucosal or systemic immunization with cholera toxin. Vaccine. 1994 Aug;12(10):903–911. doi: 10.1016/0264-410x(94)90033-7. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES